This independent website, launched January 2019, is dedicated to providing HD safety information for oncology nurses. No corporate sponsorship has been accepted. Products mentioned are for information only and do not necessarily represent an endorsement.
About

Hazardous Drug (HD) Resource
for Nursing Safety
Use top menu to find information on:
-
Hazardous Drug Excreta
-
USP <800>
-
PPE
-
Respiratory Protection
-
HD Spills
-
Monoclonal Antibodies
-
Wipe Testing & Deactivation
-
Closed System Transfer Devices
How Did We Get Here?
You're here:
You have an interest in protecting yourself, your coworkers and your environment from the dangers associated with HDs.
I'm here:
As one of the contributing authors of the ONS Safe Handling of Hazardous Drugs, I am passionate about HD safety. This quest began in the mid-1980s while working with ultra high-dose cyclophosphamide in Bone Marrow Transplant. I have spent more than 30 years publishing and presenting on this topic and am committed to providing information and resources for oncology professionals world-wide.

For additional information on HD Safety, download the ONS Toolkit for Safe Handling of Hazardous Drugs.
Scroll For More
OCTOBER 2024: JOEH article on toilet plume aerosols in 15 US hospitals. (open access)
AUGUST 2024: CJON article on PPE use and surface contamination related to the COVID-19 pandemic.
APRIL 2024: ONS Safe Handling of Hazardous Drugs, 4th Edition released.
MARCH 2024: AJN article on "The Occupational Hazards of Uncovered Toilets."
NOVEMBER 2023: USP <800> go-live date.
JUNE 2023: CJON article on the benefits of sequential wipe testing.
APRIL 2023: CJON article compares efficacy of plastic-backed pads to Splashblocker in reducing toilet plume aerosols.
Watch this 13 minute documentary about HD exposure and its tragic effect on an oncology pharmacist.
Read the InvestigateWest article HERE.
See video highlights of the 2025 Safer Cancer Care symposium held in Brussels. (coming soon)
Visit the Cytoprevent website to see what European countries are doing.